PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,119,380 | -20.0% | 425,515 | +7.3% | 0.00% | – |
| Q2 2023 | $1,399,277 | +15.6% | 396,396 | +1.2% | 0.00% | – |
| Q1 2023 | $1,210,111 | +75015.5% | 391,622 | +2.8% | 0.00% | – |
| Q4 2022 | $1,611 | -99.8% | 380,911 | +1.7% | 0.00% | – |
| Q3 2022 | $887,000 | -15.8% | 374,666 | +1.2% | 0.00% | – |
| Q2 2022 | $1,054,000 | -38.9% | 370,091 | -38.3% | 0.00% | – |
| Q1 2022 | $1,726,000 | -10.9% | 599,414 | -5.9% | 0.00% | – |
| Q4 2021 | $1,937,000 | -54.5% | 637,292 | +5.0% | 0.00% | -100.0% |
| Q3 2021 | $4,256,000 | -25.3% | 607,151 | -2.2% | 0.00% | 0.0% |
| Q2 2021 | $5,701,000 | -2.6% | 621,126 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $5,855,000 | +8.4% | 602,388 | +14.4% | 0.00% | 0.0% |
| Q4 2020 | $5,400,000 | -0.5% | 526,339 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $5,427,000 | -1.3% | 537,885 | +2.1% | 0.00% | 0.0% |
| Q2 2020 | $5,496,000 | +37.8% | 527,015 | +11.6% | 0.00% | 0.0% |
| Q1 2020 | $3,987,000 | -59.7% | 472,437 | -58.3% | 0.00% | 0.0% |
| Q4 2019 | $9,904,000 | +128.5% | 1,132,086 | +181.1% | 0.00% | 0.0% |
| Q3 2019 | $4,335,000 | -13.6% | 402,740 | +2.1% | 0.00% | 0.0% |
| Q2 2019 | $5,015,000 | -65.0% | 394,612 | +7.0% | 0.00% | -75.0% |
| Q1 2019 | $14,310,000 | +4.7% | 368,920 | -45.1% | 0.00% | +100.0% |
| Q4 2018 | $13,668,000 | -8.0% | 671,738 | +107.3% | 0.00% | -50.0% |
| Q3 2018 | $14,856,000 | -17.6% | 324,029 | +6.4% | 0.00% | -33.3% |
| Q2 2018 | $18,019,000 | -11.2% | 304,633 | +2.1% | 0.01% | -14.3% |
| Q1 2018 | $20,303,000 | -29.3% | 298,357 | +2.6% | 0.01% | -30.0% |
| Q4 2017 | $28,733,000 | -15.2% | 290,691 | +2.7% | 0.01% | -23.1% |
| Q3 2017 | $33,879,000 | +49.9% | 282,919 | +9.4% | 0.01% | +44.4% |
| Q2 2017 | $22,596,000 | +161.4% | 258,540 | +11.3% | 0.01% | +125.0% |
| Q1 2017 | $8,644,000 | +42.1% | 232,371 | +17.3% | 0.00% | +33.3% |
| Q4 2016 | $6,084,000 | -47.1% | 198,181 | +15.4% | 0.00% | -50.0% |
| Q3 2016 | $11,511,000 | +163.0% | 171,691 | +16.8% | 0.01% | +200.0% |
| Q2 2016 | $4,377,000 | +14.7% | 146,950 | +13.1% | 0.00% | 0.0% |
| Q1 2016 | $3,816,000 | -61.7% | 129,935 | +2.2% | 0.00% | -66.7% |
| Q4 2015 | $9,969,000 | +8.7% | 127,162 | +4.4% | 0.01% | 0.0% |
| Q3 2015 | $9,170,000 | -37.6% | 121,780 | -3.4% | 0.01% | -25.0% |
| Q2 2015 | $14,702,000 | -53.7% | 126,036 | -6.4% | 0.01% | -55.6% |
| Q1 2015 | $31,787,000 | +36.1% | 134,628 | +9.1% | 0.02% | +28.6% |
| Q4 2014 | $23,354,000 | -20.2% | 123,395 | +0.6% | 0.01% | -26.3% |
| Q3 2014 | $29,256,000 | +278.0% | 122,635 | +4.6% | 0.02% | +280.0% |
| Q2 2014 | $7,739,000 | -36.4% | 117,265 | +0.3% | 0.01% | -37.5% |
| Q1 2014 | $12,174,000 | +14.8% | 116,901 | +14.2% | 0.01% | +14.3% |
| Q4 2013 | $10,600,000 | +95.4% | 102,393 | +1.3% | 0.01% | +75.0% |
| Q3 2013 | $5,425,000 | +201.1% | 101,094 | +148.9% | 0.00% | +100.0% |
| Q2 2013 | $1,802,000 | – | 40,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |